The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region
Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Taluka level transplant centre will add convenience to patients from rural areas
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Subscribe To Our Newsletter & Stay Updated
